Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis

Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side‐effects and stabilize plasma glucose levels.

Detalles Bibliográficos
Autores principales: Kato, Rina, Nishimura, Akihiro, Matsumura, Kimio, Kikuno, Shota, Nagasawa, Kaoru, Mori, Yasumichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813030/
https://www.ncbi.nlm.nih.gov/pubmed/33489173
http://dx.doi.org/10.1002/ccr3.3514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813030/
https://www.ncbi.nlm.nih.gov/pubmed/33489173
http://dx.doi.org/10.1002/ccr3.3514

Ejemplares similares